购物车
全部删除
您的购物车当前为空
ACT-777991为一种选择性、口服生效的CXCR3拮抗剂,于动物模型中展现出微粒体及肝细胞稳定性,能抑制活化T细胞向CXCL11迁移。

ACT-777991为一种选择性、口服生效的CXCR3拮抗剂,于动物模型中展现出微粒体及肝细胞稳定性,能抑制活化T细胞向CXCL11迁移。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 21,600 | 10-14周 | |
| 50 mg | ¥ 28,800 | 10-14周 | |
| 100 mg | ¥ 37,500 | 10-14周 |
ACT-777991 相关产品
| 产品描述 | ACT-777991 is an orally active, selective CXCR3 antagonist with demonstrated stability in microsomes and hepatocytes across various animal models. This compound effectively inhibits the migration of activated T cells toward CXCL11. |
| 分子量 | 550.48 |
| 分子式 | C20H20F6N8O2S |
| CAS No. | 1967811-46-6 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容